Storm Therapeutics
Business Description STORM Therapeutics is a University of Cambridge spin-out, translating the ground-breaking work of Professors Tony Kouzarides and Eric Miska in RNA epigenetics into the discovery of first-in-class drugs in oncology and other diseases. It is the leading company currently tackling disease through modulating RNA modifying enzymes and is developing a unique platform to address these enzyme classes, including RNA methyltransferases.
STORM is backed by blue chip investors Cambridge Innovation Capital, Merck Ventures, Pfizer Ventures, Taiho Ventures LLC, IP Group and Seroba Life Sciences who share the founders’ ambitions to build a world-leading company in the field. To date, STORM Therapeutics has raised £30million of funding.
Based in Cambridge, Cambridgeshire
Tags Biotechnology, Health Care, Medical, Therapeutics
Website http://www.stormtherapeutics.com/
Articles about Storm Therapeutics:
💡 You're a corporate or investor and looking for startups that are innovating in the same market as
Storm Therapeutics? We're happy to assist you with our
Startup Sourcing service.